Variant report
Variant | esv3480674 |
---|---|
Chromosome Location | chr12:30370210-30373058 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-TSPAN11-5 | chr12:30370536-30370849 | ENSG00000257262 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs556956178 | chr12:30370272-30370273 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs115590774 | chr12:30370320-30370321 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs559116020 | chr12:30370334-30370335 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs189794455 | chr12:30370406-30370407 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs2037413 | chr12:30370430-30370431 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs553935420 | chr12:30370441-30370442 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs553110226 | chr12:30370457-30370458 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs141722384 | chr12:30370467-30370468 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs145160649 | chr12:30370475-30370476 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs183166102 | chr12:30370499-30370500 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs574894797 | chr12:30370519-30370520 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs558271822 | chr12:30370525-30370526 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs61748343 | chr12:30370557-30370558 | Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs12580145 | chr12:30370631-30370632 | Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs2035547 | chr12:30370651-30370652 | Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs541311687 | chr12:30370652-30370653 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
17 | rs559889768 | chr12:30370669-30370670 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
18 | rs530194773 | chr12:30370714-30370715 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
19 | rs114895216 | chr12:30370732-30370733 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
20 | rs187897151 | chr12:30370738-30370739 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
21 | rs562223997 | chr12:30370756-30370757 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
22 | rs574401887 | chr12:30370794-30370795 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
23 | rs112006751 | chr12:30370804-30370805 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
24 | rs11050722 | chr12:30370825-30370826 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs11050723 | chr12:30370849-30370850 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs144467013 | chr12:30371638-30371639 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs540980704 | chr12:30371655-30371656 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs7976149 | chr12:30371753-30371754 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs535302643 | chr12:30371764-30371765 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs539767085 | chr12:30371797-30371798 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs73078524 | chr12:30371803-30371804 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs568860654 | chr12:30371813-30371814 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs188398349 | chr12:30371825-30371826 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs372623966 | chr12:30371976-30371977 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs557727917 | chr12:30371996-30371997 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs566465658 | chr12:30372019-30372020 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs7979205 | chr12:30372030-30372031 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs140417426 | chr12:30372046-30372047 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs192838917 | chr12:30372047-30372048 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs559469368 | chr12:30372095-30372096 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs557585297 | chr12:30372109-30372110 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs184843614 | chr12:30372138-30372139 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs145527118 | chr12:30372139-30372140 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs112180895 | chr12:30372153-30372154 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs528505503 | chr12:30372156-30372157 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs540252999 | chr12:30372160-30372161 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs562240365 | chr12:30372162-30372163 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs2351225 | chr12:30372166-30372167 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs113914552 | chr12:30372167-30372168 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs186683190 | chr12:30372194-30372195 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Wilms tumour | 21544195 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Testicular cancer | 18059402 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Seminomas | 18059402 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 21858162 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 20164919 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Breast cancer | 21509527 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Breast cancer | 17133270 | CNVD |
Cancer | 21129771 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17899364 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Glioma | 20126413 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:30370200-30370800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
2 | chr12:30371600-30372400 | Enhancers | Osteobl | bone |
3 | chr12:30372200-30373400 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |